冠状动脉旁路移植术长期生存预测:ASCERT模型与胸外科医师学会预测死亡风险模型的验证比较
该研究基于654例65岁及以上接受孤立冠状动脉旁路移植术患者的机构数据,外部验证ASCERT长期生存概率计算器,并与STS短期预测死亡风险模型比较。结果显示两模型对7年生存预测的区分度相当(C统计量分别为0.815和0.781),校准良好,均可为术前决策和患者咨询提供信息。
要点
- ASCERT模型在全部风险组中均获得外部验证,预测与实际生存曲线无显著差异。
- STS PROM对长期生存的预测性能与ASCERT相当(C统计量0.781 vs 0.815)。
- 延长通气、卒中和住院时间也是长期死亡的预测因素。
核心结论
- ASCERT生存概率计算器在所有风险组中均获得外部验证,可用于预测冠状动脉旁路移植术后长期生存。
- 广泛使用的STS PROM作为长期生存预测因素表现相当。
- 两种工具均为术前决策和患者咨询提供重要信息。
研究设计与样本
- 回顾性审查2005年至2010年间654例65岁及以上接受孤立冠状动脉旁路移植术患者的机构数据。
- 使用ASCERT模型计算预测生存概率,通过社会保障死亡索引和机构病历收集生存数据。
- 对总体样本及基于ASCERT 7年生存概率和STS短期风险计算器预测死亡风险分层的亚组评估模型校准和区分度,并进行逻辑回归分析评估围术期变量对死亡的贡献。
主要发现
- 总体生存率1年为92.1%(569/597),7年为50.5%(164/325)。
- 校准评估显示总体样本及按预测7年生存或PROM分层的亚组中,预测与否则生存曲线均无显著差异。
- 7年生存预测的区分度:ASCERT的C统计量为0.815,PROM的C统计量为0.781(两者p < 0.001)。
- 延长通气、卒中和住院时间也是长期死亡的预测因素。
临床怎么用
- 原文结论指出,ASCERT和STS PROM两种工具均为术前决策和患者咨询提供重要信息。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The recently developed American College of Cardiology Foundation-Society of Thoracic Surgeons (STS) Collaboration on the Comparative Effectiveness of Revascularization Strategy (ASCERT) Long-Term Survival Probability Calculator is a valuable addition to existing short-term risk-prediction tools for cardiac surgical procedures but has yet to be externally validated. METHODS: Institutional data of 654 patients aged 65 years or older undergoing isolated coronary artery bypass grafting between 2005 and 2010 were reviewed. Predicted survival probabilities were calculated using the ASCERT model. Survival data were collected using the Social Security Death Index and institutional medical records. Model calibration and discrimination were assessed for the overall sample and for risk-stratified subgroups based on (1) ASCERT 7-year survival probability and (2) the predicted risk of mortality (PROM) from the STS Short-Term Risk Calculator. Logistic regression analysis was performed to evaluate additional perioperative variables contributing to death. RESULTS: Overall survival was 92.1% (569 of 597) at 1 year and 50.5% (164 of 325) at 7 years. Calibration assessment found no significant differences between predicted and actual survival curves for the overall sample or for the risk-stratified subgroups, whether stratified by predicted 7-year survival or by PROM. Discriminative performance was comparable between the ASCERT and PROM models for 7-year survival prediction (p < 0.001 for both; C-statistic = 0.815 for ASCERT and 0.781 for PROM). Prolonged ventilation, stroke, and hospital length of stay were also predictive of long-term death. CONCLUSIONS: The ASCERT survival probability calculator was externally validated for prediction of long-term survival after coronary artery bypass grafting in all risk groups. The widely used STS PROM performed comparably as a predictor of long-term survival. Both tools provide important information for preoperative decision making and patient counseling about potential outcomes after coronary artery bypass grafting.
引用
- Lancaster TS, Schill MR, Greenberg JW, et al. Long-Term Survival Prediction for Coronary Artery Bypass Grafting: Validation of the ASCERT Model Compared With The Society of Thoracic Surgeons Predicted Risk of Mortality. Ann Thorac Surg. 2017. PMID: 29273200. doi:10.1016/j.athoracsur.2017.11.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。